Li Cun, Yu Yifei, Wan Zhixin, Chiu Man Chun, Huang Jingjing, Zhang Shuxin, Zhu Xiaoxin, Lan Qiaoshuai, Deng Yanlin, Zhou Ying, Xue Wei, Yue Ming, Cai Jian-Piao, Yip Cyril Chik-Yan, Wong Kenneth Kak-Yuen, Liu Xiaojuan, Yu Yang, Huang Lin, Chu Hin, Chan Jasper Fuk-Woo, Clevers Hans, Yuen Kwok Yung, Zhou Jie
Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.
Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, China.
Nat Commun. 2024 Dec 30;15(1):10772. doi: 10.1038/s41467-024-55076-2.
The lack of a robust system to reproducibly propagate HRV-C, a family of viruses refractory to cultivation in standard cell lines, has substantially hindered our understanding of this common respiratory pathogen. We sought to develop an organoid-based system to reproducibly propagate HRV-C, and characterize virus-host interaction using respiratory organoids. We demonstrate that airway organoids sustain serial virus passage with the aid of CYT387-mediated immunosuppression, whereas nasal organoids that more closely simulate the upper airway achieve this without any intervention. Nasal organoids are more susceptible to HRV-C than airway organoids. Intriguingly, upon HRV-C infection, we observe an innate immune response that is stronger in airway organoids than in nasal organoids, which is reproduced in a Poly(I:C) stimulation assay. Treatment with α-CDHR3 and antivirals significantly reduces HRV-C viral growth in airway and nasal organoids. Additionally, an organoid-based immunofluorescence assay is established to titrate HRV-C infectious particles. Collectively, we develop an organoid-based system to reproducibly propagate the poorly cultivable HRV-C, followed by a comprehensive characterization of HRV-C infection and innate immunity in physiologically active respiratory organoids. The organoid-based HRV-C infection model can be extended for developing antiviral strategies. More importantly, our study has opened an avenue for propagating and studying other uncultivable human and animal viruses.
由于缺乏一个能可靠地繁殖HRV-C(一类难以在标准细胞系中培养的病毒)的强大系统,我们对这种常见呼吸道病原体的了解受到了极大阻碍。我们试图开发一种基于类器官的系统来可靠地繁殖HRV-C,并使用呼吸道类器官来表征病毒与宿主的相互作用。我们证明,气道类器官在CYT387介导的免疫抑制作用下能够维持病毒的连续传代,而更接近模拟上呼吸道的鼻类器官在没有任何干预的情况下就能做到这一点。鼻类器官比气道类器官对HRV-C更敏感。有趣的是,在HRV-C感染后,我们观察到气道类器官中的固有免疫反应比鼻类器官中的更强更强,这在聚肌胞苷酸(Poly(I:C))刺激试验中得到了重现。用α-CDHR3和抗病毒药物进行处理可显著降低气道和鼻类器官中HRV-C的病毒生长。此外,还建立了一种基于类器官的免疫荧光测定法来滴定HRV-C感染性颗粒。总的来说,我们开发了一种基于类器官的系统来可靠地繁殖难以培养的HRV-C,随后对生理活性呼吸道类器官中的HRV-C感染和固有免疫进行了全面表征。基于类器官的HRV-C感染模型可扩展用于开发抗病毒策略。更重要的是,我们的研究为繁殖和研究其他难以培养的人类和动物病毒开辟了一条途径。